|
|
Volumn 66, Issue 4, 1999, Pages 207-208
|
|
Should methotrexate be a first-line treatment for rheumatoid arthritis?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
FOLIC ACID;
IMMUNOSUPPRESSIVE AGENT;
LEFLUNOMIDE;
METHOTREXATE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ARTHRITIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LIVER TOXICITY;
META ANALYSIS;
NOTE;
PATIENT MONITORING;
RHEUMATOID ARTHRITIS;
TREATMENT INDICATION;
|
|
EID: 0033064772
PISSN: 08911150
EISSN: None
Source Type: Journal
DOI: 10.3949/ccjm.66.4.207 Document Type: Note |
|
Times cited : (2)
|
|
References (16)
|
